ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABCL AbCellera Biologics Inc

3.635
-0.265 (-6.79%)
Last Updated: 01:51:36
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AbCellera Biologics Inc ABCL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.265 -6.79% 3.635 01:51:36
Open Price Low Price High Price Close Price Previous Close
3.86 3.62 3.86 3.90
more quote information »

Recent News

Date Time Source Heading
09/4/202402:05BWAbCellera Presents Data on T-Cell Engagers Against Four..
04/4/202407:05BWAbCellera to Report First Quarter 2024 Financial Results on..
20/3/202407:05BWAbCellera to Present at the Bloom Burton Healthcare..
12/3/202400:00BWAbCellera to Collaborate with Biogen to Discover Therapeutic..
06/3/202408:30BWAbCellera Announces Four Presentations on T-Cell Engagers at..
28/2/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202408:49EDGAR2Form 8-K - Current report
24/2/202408:30BWAbCellera Announces Resignation of Board Member
23/2/202412:15BWAbCellera to Present at Upcoming Investor Conferences in..
21/2/202408:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/2/202408:27EDGAR2Form 8-K - Current report
21/2/202408:05BWAbCellera Reports Full Year 2023 Business Results
24/1/202408:05BWAbCellera to Report Full Year 2023 Financial Results on..
17/1/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:05BWAbCellera to Present at the 42nd Annual J.P. Morgan..
20/12/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202309:28EDGAR2Form 8-K - Current report
28/11/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202308:05BWAbCellera to Present at the Piper Sandler 35th Annual..
09/11/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202303:05BWAbCellera Presents New Data on Two T-Cell Engager Programs..
03/11/202307:13EDGAR2Form 8-K - Current report
03/11/202307:05BWAbCellera Reports Q3 2023 Business Results
02/11/202307:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
01/11/202307:05BWAbCellera to Present at the Jefferies London Healthcare..
12/10/202307:05BWAbCellera to Report Third Quarter 2023 Financial Results on..
27/9/202323:00BWAbCellera Announces Two T-Cell Engager Presentations at SITC..
21/9/202307:02BWAbCellera Expands Multi-Target Antibody Discovery..
20/9/202323:00BWAbCellera Expands Multi-Target Antibody Discovery..
15/9/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202323:00BWAbCellera Announces Collaboration with Incyte to Accelerate..
26/8/202303:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:15EDGAR2Form 8-K - Current report
04/8/202306:05BWAbCellera Reports Q2 2023 Business Results
25/7/202306:05BWAbCellera Announces that the U.S. Patent Trial and Appeal..
07/7/202306:05BWAbCellera to Report Second Quarter 2023 Financial Results on..
30/5/202306:05BWAbCellera to Present at the Goldman Sachs 44th Annual Global..
25/5/202303:10BWAbCellera Partners with the Governments of Canada and..
05/5/202306:05BWAbCellera Reports Q1 2023 Business Results

Your Recent History

Delayed Upgrade Clock